Evolutionary Genomics Financial Leverage

Financial Leverage (Equity Multiplier) of Evolutionary Genomics is -1.50 in 2026.

Financial Leverage (Equity Multiplier) of Evolutionary Genomics changed from -3.53 to -1.50, representing a -57.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Evolutionary Genomics with sector peers and the industry average to assess whether it is attractive.